Celgene is opening its wallet yet again, but to what end? The struggling biotech giant announced Thursday that it plans to spend $2 billion on an accelerated stock …
“This turnover raises questions about how much value to give to those programs …
Celgene Corporation (NASDAQ: CELG) today announced that the Company's …
ticker=CELG Foundation Medicine, Inc. https://rdinvesting.com/news/?ticker=FMI Celgene's stock moved 4.7% lower Monday, to close the day at $74.69. The stock recorded a trading volume of 18,588,718 shares, which was above its …
The board of Celgene (NASDAQ:CELG) has authorized the repurchase of an additional $3B of its common stock and the accelerated repurchase of $2B of stock. The accelerated buybacks will use part of the existing authorized repurchase …
At this point, CELG stock is simply a falling knife. Once the $95 level gave way it’s been like an avalanche lower. The hope for bulls now is that support comes into …
Repurchases by top 20 firms at highest in at least a decade Amgen, Pfizer, …
SmarTrend identified a Downtrend for Celgene Corp (NASDAQ:CELG) on October 13th, 2017 at $137.01. In approximately 7 months, Celgene Corp has returned 44.80% as of today's recent price of $75.62. In the past 52 weeks, Celgene Corp …
Celgene shares pared some of yesterday's losses in pre-market trading. On Monday, the stock fell 4.70% following a report that business development head George …
(RTTNews.com) - Celgene Corp. ( CELG) announced that its board authorized the repurchase of an additional $3 billion of the Company's common stock. In addition, the company plans to enter into an accelerated share repurchase …